Company intelligence / Profile preview

Southern XP Pharmaceuticals

Sydney, New South Wales, Australia

Ownership: Private
Development stage: Other

Overview

Southern XP Pharmaceuticals is an Australian-based pharmaceutical company focused on the development of improved formulations of existing pain management medications. The company specializes in creating value-added generic products using proprietary formulation technologies to enhance the safety and efficacy profiles of established drugs. Its lead programs involve optimized delivery systems for opioid analgesics designed to provide rapid onset of action while potentially reducing side effects. Southern XP primarily targets the global pain management market through strategic clinical development and regulatory pathways.

Therapeutic areas: Neurology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Southern XP Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Southern XP Pharmaceuticals.

Explore the full profile